Depressive and alcohol use disorders were significantly associated with increased mortality (HR 1.97 and HR 1.72, respectively) over an 8-year follow-up.
Cohort
Are depressive, anxiety, and alcohol use disorders associated with increased mortality in a nationally representative sample of adults?
Depressive and alcohol use disorders are associated with an increased mortality risk comparable to many chronic somatic conditions, independent of sociodemographic and somatic health status.
Estimación del efecto: HR 1.97 (depressive), HR 1.72 (alcohol use)
BACKGROUND: Mental disorders are associated with increased mortality, but population-based surveys with reliable diagnostic procedures controlling for somatic health status are scarce. AIMS: To assess excess mortality associated with depressive, anxiety and alcohol use disorders and the principal causes of death. METHOD: In a nationally representative sample of Finns aged 30-70 years, psychiatric disorders were diagnosed with the Composite International Diagnostic Interview. After an 8-year follow-up period, vital status and cause of death of each participant was obtained from national registers. RESULTS: After adjusting for sociodemographic factors, health status and smoking, depressive (hazard ratio (HR) = 1.97) and alcohol use disorders (HR = 1.72) were statistically significantly associated with mortality. Risk of unnatural death was increased among individuals diagnosed with anxiety disorders or alcohol dependence. CONCLUSIONS: Individuals with depressive and alcohol use disorders have an increased mortality risk comparable with many chronic somatic conditions, that is only partly attributable to differences in sociodemographic, somatic health status and hazardous health behaviour.
Markkula et al. (Fri,) conducted a cohort in Depressive, anxiety and alcohol use disorders. Depressive, anxiety and alcohol use disorders was evaluated on Mortality (HR 1.97 (depressive), HR 1.72 (alcohol use)). Depressive and alcohol use disorders were significantly associated with increased mortality (HR 1.97 and HR 1.72, respectively) over an 8-year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: